We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Oxford Nanoimaging -- a University of Oxford spinout -- will commence sales of an elegant desktop optical microscope capable of zooming in on objects as tiny as structures inside living cells. This super-resolution microscope will allow scientists to watch how individual molecules perform chemical reactions in real-time.
One of the most ambitious Oxford spinouts to date is on route to becoming a powerhouse in age-related regenerative medicine, developing drugs which can treat cancer, neurodegenerative diseases, heart failure, macular degeneration and other major age-related conditions
- Universal flu vaccine developed at Oxford already showing promise in Phase II clinical trials
- Large investment of £10m from Oxford Sciences Innovation
- Further programs include vaccines to boost cancer immunotherapies
Oxford spinout EvOx Therapeutics will harness the body’s own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.
iOutcomes at the ISPOR 21st Annual International Meeting to be held in Washington, from May 21st – 25th, 2016.
Genomics plc and DNAnexus collaborate to develop solutions for population-scale sequencing analysis
Oxford businesses who wish to share their expertise and resources now have a network through which to engage with entrepreneurs and new Oxford startup ventures. The network is managed and run by the University’s Isis Startup Incubator.